Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
99.96
+0.13 (0.13%)
Oct 8, 2025, 9:41 AM EDT - Market open
Rhythm Pharmaceuticals Stock Forecast
Stock Price Forecast
The 13 analysts that cover Rhythm Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $109.77, which forecasts a 9.82% increase in the stock price over the next year. The lowest target is $65 and the highest is $142.
Price Target: $109.77 (+9.82%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Rhythm Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $100 → $110 | Strong Buy | Maintains | $100 → $110 | +10.05% | Sep 29, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $109 → $122 | Buy | Maintains | $109 → $122 | +22.05% | Sep 25, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $135 → $142 | Buy | Maintains | $135 → $142 | +42.06% | Sep 25, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $105 → $138 | Strong Buy | Maintains | $105 → $138 | +38.06% | Sep 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $100 | Strong Buy | Maintains | $80 → $100 | +0.05% | Aug 7, 2025 |
Financial Forecast
Revenue This Year
190.12M
from 130.13M
Increased by 46.10%
Revenue Next Year
304.93M
from 190.12M
Increased by 60.39%
EPS This Year
-3.07
from -4.34
EPS Next Year
-2.14
from -3.07
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 208.1M | 385.5M | |||
| Avg | 190.1M | 304.9M | |||
| Low | 170.8M | 236.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 59.9% | 102.7% | |||
| Avg | 46.1% | 60.4% | |||
| Low | 31.3% | 24.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.89 | -0.66 | |||
| Avg | -3.07 | -2.14 | |||
| Low | -3.34 | -3.59 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.